OTCMKTS:WINT - Windtree Therapeutics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $2.88 0.00 (0.00 %) (As of 10/21/2018 12:27 PM ET)Previous Close$2.88Today's Range$2.88 - $2.8852-Week Range$2.05 - $4.00Volume26 shsAverage Volume1,379 shsMarket Capitalization$10.86 millionP/E RatioN/ADividend YieldN/ABeta1.83 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Windtree Therapeutics, Inc., a biotechnology company, focuses on developing surfactant therapies for respiratory diseases and other potential applications. Its proprietary technology platform includes a synthetic peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and drug-delivery technologies being developed to enable the noninvasive administration of aerosolized KL4 surfactant. The company's lead development program comprises AEROSURF, a drug/device product that has completed Phase IIb clinical trial to treat respiratory distress syndrome in premature infants. It is also developing other aerosolized KL4 surfactant products. Windtree Therapeutics, Inc. has a strategic collaboration with Eleison Pharmaceuticals, Inc. for using its proprietary aerosol delivery system to deliver inhaled lipid cisplatin in combination with KL4 surfactant. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania. Receive WINT News and Ratings via Email Sign-up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biological products, except diagnostic Sub-IndustryBiotechnology SectorMedical SymbolOTCMKTS:WINT CUSIP25466840 Webwww.windtreetx.com Phone215-488-9300 Debt Debt-to-Equity Ratio-0.53 Current Ratio0.07 Quick Ratio0.07 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.48 million Price / Sales7.34 Cash FlowN/A Price / CashN/A Book Value($7.57) per share Price / Book-0.38 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-18,440,000.00 Net Margins-756.97% Return on EquityN/A Return on Assets-326.22% Miscellaneous Employees29 Outstanding Shares3,770,000Market Cap$10.86 million Windtree Therapeutics (OTCMKTS:WINT) Frequently Asked Questions What is Windtree Therapeutics' stock symbol? Windtree Therapeutics trades on the OTCMKTS under the ticker symbol "WINT." How were Windtree Therapeutics' earnings last quarter? Windtree Therapeutics Inc (OTCMKTS:WINT) released its quarterly earnings data on Tuesday, August, 14th. The biotechnology company reported ($0.81) EPS for the quarter. The biotechnology company had revenue of $1.05 million for the quarter. View Windtree Therapeutics' Earnings History. When is Windtree Therapeutics' next earnings date? Windtree Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, November 13th 2018. View Earnings Estimates for Windtree Therapeutics. Who are some of Windtree Therapeutics' key competitors? Some companies that are related to Windtree Therapeutics include BIONDVAX PHARMA/S (BVXV), Proteon Therapeutics (PRTO), CytRx (CYTR), Vical (VICL), Vaxart (VXRT), Arsanis (ASNS), aTyr Pharma (LIFE), TrovaGene (TROV), Genetic Technologies (GENE), Mymetics (MYMX), Microbot Medical (MBOT), Neuralstem (CUR), Enzon Pharmaceuticals (ENZN), Mateon Therapeutics (MATN) and Titan Pharmaceuticals (TTNP). Who are Windtree Therapeutics' key executives? Windtree Therapeutics' management team includes the folowing people: Mr. Craig E. Fraser, Pres, CEO & Director (Age 53)Mr. John A. Tattory, Sr. VP, CFO & Treasurer (Age 52)Dr. Steven G. Simonson, Sr. VP & Chief Medical Officer (Age 59)Mr. George Cox, VP of Manufacturing & Supply Chain and Technical Operations (Age 66)Ms. Mary B. Templeton, Sr. VP, Gen. Counsel & Corp. Sec. (Age 71) How do I buy shares of Windtree Therapeutics? Shares of WINT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Windtree Therapeutics' stock price today? One share of WINT stock can currently be purchased for approximately $2.88. How big of a company is Windtree Therapeutics? Windtree Therapeutics has a market capitalization of $10.86 million and generates $1.48 million in revenue each year. Windtree Therapeutics employs 29 workers across the globe. What is Windtree Therapeutics' official website? The official website for Windtree Therapeutics is http://www.windtreetx.com. How can I contact Windtree Therapeutics? Windtree Therapeutics' mailing address is 2600 KELLY ROAD SUITE 100, WARRINGTON PA, 18976. The biotechnology company can be reached via phone at 215-488-9300 or via email at [email protected] MarketBeat Community Rating for Windtree Therapeutics (OTCMKTS WINT)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 115 (Vote Outperform)Underperform Votes: 100 (Vote Underperform)Total Votes: 215MarketBeat's community ratings are surveys of what our community members think about Windtree Therapeutics and other stocks. Vote "Outperform" if you believe WINT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WINT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/21/2018 by MarketBeat.com StaffFeatured Article: Hedge Funds - Risk or Reward?